Molekule Group, Inc. Balance Sheet

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
Current assets:
Cash
Restricted Cash
Accounts receivable
Prepaid expenses and other current assets
Inventories
Total current assets
Property and equipment, net
Intangible assets, net
Goodwill
Operating lease right-of-use assets
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Current operating lease liability
Notes payable, current portion
Total current liabilities
Long-term liabilities:
Warrant liability
Warrant liability, at fair value
Notes payable, net of current portion
Long-term operating lease liability
Deferred tax liability
Total liabilities
Stockholders' equity:
Common stock, $0.01 par value per share; 110,000,000 shares authorized; 34,002,750 and 15,496,932 issued and outstanding as of June 30, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated deficit
Total members'/stockholders' equity
Total stockholders' equity
Total liabilities and stockholders' equity

Comments